Metraipolis › archive › dc_19fcbfa40b74
Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study — Europe PMC PMID:41556438
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41556438
- DOI
- 10.1002/advs.202515952
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T06:08:48.204Z
- SHA-256 of the archived text
1b1bbe711cdf5801f6e42e2481867fe9d7ea01365f954abf1074afa12589addf- Stable URL of this page
https://metraipolis.com/documento/dc_19fcbfa40b74
How to cite
Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study — Europe PMC PMID:41556438 — Europe PMC (en), https://europepmc.org/article/MED/41556438 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19fcbfa40b74 (Metraipolis archive dc_19fcbfa40b74, sha256 1b1bbe711cdf5801f6e42e2481867fe9d7ea01365f954abf1074afa12589addf)
BibTeX
@misc{dc19fcbfa40b74,
title = {Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study — Europe PMC PMID:41556438},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41556438},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19fcbfa40b74; sha256 1b1bbe711cdf5801f6e42e2481867fe9d7ea01365f954abf1074afa12589addf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41556438. Agents can read the archived copy with the MCP tool read_document.